Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06596902 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Promoting Physical Activity and Fitness Among Underserved Latino Families Living in U.S.-Mexico Border Regions

Study acronym: AFL
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Secondary endpoints: details revised at 1 of 1 entry
    • Eligibility criteria expanded, about 4 words
  2. Lead sponsor: Noe Crespo to San Diego State University
    • Trial status: Active, Not Recruiting to Recruiting
    • Site details revised
    • Collaborators: 3 to 2
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
San Diego State University
59 trials monitored
See 1 trial at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Obesity
3,874 trials monitored
See 152 trials at risk
This study has the goal to increase physical activity and fitness among Latinos in San Diego, California and Mexicali, Baja California (U.S.-Mexico border) since these cities have similar diseases such as high rates of heart disease and obesity. Therefore there is a need to have physical activity programs for children and their families. We will collaborate with community centers to have this program available.
Trial Details
NCT Number NCT06596902
Lead Sponsor San Diego State University
Collaborators: Universidad Autonoma de Baja California, National Institute on Minority Health and Health Disparities (NIMHD)
Conditions
(from sponsor)		 Obesity Prevention, Heart Disease
Related terms Heart Diseases
Enrollment 290 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov